Communication About Prognosis and Illness Understanding Among Adults Receiving Targeted Therapy (TTx) for Metastatic Non-Small Cell Lung Cancer (mNSCLC) (RP315)
Precision medicine has dramatically improved survival for a subset of adults with mNSCLC, yet mNSCLC remains a life-limiting illness. Prognostic awareness allows patients and caregivers to plan for the future and discuss preferences with their medical team.
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Laura Petrillo, Robert Sommer, Lara Traeger, Joseph Greer, Jennifer Temel Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Pain | Pain Management | Palliative Care